For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...

Left atrial appendage occlusion (LAAO) during cardiac surgery in patients with atrial fibrillation was associated with lower stroke-related disability and reduced risk for 30-day mortality and ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

Kauvery Hospital, Alwarpet, has successfully performed a complex and advanced cardiac procedure combining Transcatheter ...

SAN FRANCISCO — Thirteen months after percutaneous left atrial appendage closure (LAAC), outcomes did not differ whether closure was performed using the Amulet (Abbott Cardiovascular) or the Watchman ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Kauvery Hospital, Alwarpet, successfully completed an innovative cardiac procedure, combining MitraClip and Left Atrial ...

Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's FARAPULSE™ Pulsed Field Ablation (PFA) Platform and WATCHMAN™ Left Atrial Appendage Closure (LAAC) ...

Structural heart news arrived in a steady stream throughout 2025—from pivotal trials to approvals, reimbursement decisions, and real-world rollouts of novel technologies. The growth was seen in aortic ...